| abstract |
The present invention comprises compounds of Formula I. wherein: R 1 , R 2 , R 3 , R 5 , A 1 , A 2 , and Ⓐ are defined in the specification. The invention also comprises a compound of Formula I for use in a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a compound for use in a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim 1. |